Osteoporosis Management and Falls Prevention in Patients with Haemophilia: Review of Haemophilia Guidelines

Overview

Journal Haemophilia

Specialty Hematology

Date 2022 Mar 15

PMID 35290707

Authors

Madison J Petkovic

Huyen A Tran

Peter R Ebeling

Ayse Zengin

Affiliations

Soon will be listed here.

Abstract

Introduction: Patients with haemophilia (PWH) have a high prevalence of osteoporosis, falls and fractures at all ages. The role of haemophilia itself may contribute to low bone mineral density (BMD) due to coagulation factor deficiency. Guidelines for the management of osteoporosis, fracture and fall risk may help to reduce fracture and fall risk, and delay osteoporosis onset.

Aim: We aim to review current haemophilia guidelines regarding osteoporosis prevention, screening, diagnosis and management, and fall prevention.

Method: A database search (Ovid MEDLINE) revealed two haemophilia guidelines (World and British) published within the last ten years. Local Australian haemophilia guidelines were identified through a manual search.

Results: All haemophilia guidelines were found to contain inadequate recommendations for osteoporosis management and fall prevention due to a lack of evidence in the literature.

Conclusion: Further studies are required to assess the trajectory of bone health in PWH, the mechanism of bone loss in PWH, and the effectiveness of weight-bearing exercises, interventions for fall prevention, screening programmes, and use of anti-osteoporosis medications in PWH across the lifecourse.

Citing Articles

Analysis of the current status and characteristics of osteoporosis in adult hemophilia patients based on high-resolution peripheral quantitative computed tomography: a case control study.

Liu Y, Ge Y, Shi M, Zhang L, Chen L, Xia W BMC Musculoskelet Disord. 2025; 26(1):242.

PMID: 40069679 PMC: 11895144. DOI: 10.1186/s12891-025-08473-7.

Evolving strategies for osteoporosis management in postmenopausal women: From tradition to innovation.

Akbar A, Zaheer A, Kharal M, Komel A, Khan M, Ahsan A Medicine (Baltimore). 2025; 104(7):e41605.

PMID: 39960896 PMC: 11835067. DOI: 10.1097/MD.0000000000041605.

The influence of severity of hemophilia on bone mineral density and fracture risk.

Ransmann P, Hmida J, Bruhl M, Schildberg F, Goldmann G, Oldenburg J Res Pract Thromb Haemost. 2024; 8(8):102624.

PMID: 39687923 PMC: 11648757. DOI: 10.1016/j.rpth.2024.102624.

Blood-Induced Arthropathy: A Major Disabling Complication of Haemophilia.

Leuci A, Dargaud Y J Clin Med. 2024; 13(1).

PMID: 38202232 PMC: 10779541. DOI: 10.3390/jcm13010225.

Total hip and knee arthroplasty in HIV- and HCV-positive hemophilia patients: short term follow-up of 14 patients.

Wang Z, Gu Y, Wang R, Xiang S, Jin Z, Tong P BMC Musculoskelet Disord. 2023; 24(1):946.

PMID: 38057748 PMC: 10702104. DOI: 10.1186/s12891-023-07087-1.

References

Kempton C, Antoniucci D, Rodriguez-Merchan E . Bone health in persons with haemophilia. Haemophilia. 2015; 21(5):568-77. DOI: 10.1111/hae.12736. View

Iorio A, Fabbriciani G, Marcucci M, Brozzetti M, Filipponi P . Bone mineral density in haemophilia patients. A meta-analysis. Thromb Haemost. 2010; 103(3):596-603. DOI: 10.1160/TH09-09-0629. View

Barnes C, Wong P, Egan B, Speller T, Cameron F, Jones G . Reduced bone density among children with severe hemophilia. Pediatrics. 2004; 114(2):e177-81. DOI: 10.1542/peds.114.2.e177. View

Takedani K, Notsu M, Yamauchi M, Nawata K, Sugimoto T, Kanasaki K . Graves' disease and vertebral fracture: Possible pathogenic link in postmenopausal women. Clin Endocrinol (Oxf). 2020; 93(2):204-211. DOI: 10.1111/cen.14208. View

Abdelrazik N, Reda M, El-Ziny M, Rabea H . Evaluation of bone mineral density in children with hemophilia: Mansoura University children hospital (MUCH) experience, Mansoura, Egypt. Hematology. 2007; 12(5):431-7. DOI: 10.1080/10245330701383700. View

Tardy-Poncet B, Play B, Montmartin A, Damien P, Ollier E, Presles E . PHILEOS () Study: protocol of a multicentre prospective case-control study. BMJ Open. 2021; 11(1):e042283. PMC: 7812091. DOI: 10.1136/bmjopen-2020-042283. View

Beck B, Daly R, Fiatarone Singh M, Taaffe D . Exercise and Sports Science Australia (ESSA) position statement on exercise prescription for the prevention and management of osteoporosis. J Sci Med Sport. 2016; 20(5):438-445. DOI: 10.1016/j.jsams.2016.10.001. View

Raffini L, Manno C . Modern management of haemophilic arthropathy. Br J Haematol. 2007; 136(6):777-87. DOI: 10.1111/j.1365-2141.2007.06490.x. View

Khawaji M, Akesson K, Berntorp E . Long-term prophylaxis in severe haemophilia seems to preserve bone mineral density. Haemophilia. 2009; 15(1):261-6. DOI: 10.1111/j.1365-2516.2008.01912.x. View

10.

Bischoff-Ferrari H, Willett W, Wong J, Stuck A, Staehelin H, Orav E . Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009; 169(6):551-61. DOI: 10.1001/archinternmed.2008.600. View

11.

Masud T, Morris R . Epidemiology of falls. Age Ageing. 2002; 30 Suppl 4:3-7. DOI: 10.1093/ageing/30.suppl_4.3. View

12.

Srivastava A, Santagostino E, Dougall A, Kitchen S, Sutherland M, Pipe S . WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia. 2020; 26 Suppl 6:1-158. DOI: 10.1111/hae.14046. View

13.

Skinner M, Negrier C, Paz-Priel I, Chebon S, Jimenez-Yuste V, Callaghan M . The effect of emicizumab prophylaxis on long-term, self-reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies. Haemophilia. 2021; 27(5):854-865. PMC: 8518882. DOI: 10.1111/hae.14363. View

14.

Recht M, Liel M, Turner R, Klein R, Taylor J . The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption. Haemophilia. 2013; 19(6):908-12. DOI: 10.1111/hae.12195. View

15.

Vasquez H, Mazure R, Gonzalez D, Flores D, Pedreira S, Niveloni S . Risk of fractures in celiac disease patients: a cross-sectional, case-control study. Am J Gastroenterol. 2000; 95(1):183-9. DOI: 10.1111/j.1572-0241.2000.01682.x. View

16.

Rayment R, Chalmers E, Forsyth K, Gooding R, Kelly A, Shapiro S . Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B. Br J Haematol. 2020; 190(5):684-695. DOI: 10.1111/bjh.16704. View

17.

Kempton C, Makris M, Holme P . Management of comorbidities in haemophilia. Haemophilia. 2020; 27 Suppl 3:37-45. DOI: 10.1111/hae.14013. View

18.

Anagnostis P, Vakalopoulou S, Slavakis A, Charizopoulou M, Kazantzidou E, Chrysopoulou T . Reduced bone mineral density in patients with haemophilia A and B in Northern Greece. Thromb Haemost. 2012; 107(3):545-51. DOI: 10.1160/TH11-08-05563. View

19.

Runkel B, Czepa D, Hilberg T . RCT of a 6-month programmed sports therapy (PST) in patients with haemophilia - Improvement of physical fitness. Haemophilia. 2016; 22(5):765-71. DOI: 10.1111/hae.12957. View

20.

Sammels M, Vandesande J, Vlaeyen E, Peerlinck K, Milisen K . Falling and fall risk factors in adults with haemophilia: an exploratory study. Haemophilia. 2014; 20(6):836-45. DOI: 10.1111/hae.12512. View